Report Detail
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4529445 |
- 26 September, 2024 |
- Global |
- 101 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
According to our (Global Info Research) latest study, the global T-Cell & NK-Cell Engaging Bispecific Antibodies market size was valued at US$ 669 million in 2023 and is forecast to a readjusted size of USD 6905 million by 2030 with a CAGR of 40.0% during review period.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.
This report is a detailed and comprehensive analysis for global T-Cell & NK-Cell Engaging Bispecific Antibodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global T-Cell & NK-Cell Engaging Bispecific Antibodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global T-Cell & NK-Cell Engaging Bispecific Antibodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global T-Cell & NK-Cell Engaging Bispecific Antibodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for T-Cell & NK-Cell Engaging Bispecific Antibodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global T-Cell & NK-Cell Engaging Bispecific Antibodies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Immunocore, Johnson & Johnson, Roche, Pfizer, AbbVie, MacroGenics, Regeneron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
T-Cell & NK-Cell Engaging Bispecific Antibodies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
T-Cell Engagers
NK-Cell Engagers
Market segment by Application
Hematological Cancers
Solid Tumors
Major players covered
Amgen
Immunocore
Johnson & Johnson
Roche
Pfizer
AbbVie
MacroGenics
Regeneron
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe T-Cell & NK-Cell Engaging Bispecific Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, with price, sales quantity, revenue, and global market share of T-Cell & NK-Cell Engaging Bispecific Antibodies from 2019 to 2024.
Chapter 3, the T-Cell & NK-Cell Engaging Bispecific Antibodies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the T-Cell & NK-Cell Engaging Bispecific Antibodies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and T-Cell & NK-Cell Engaging Bispecific Antibodies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of T-Cell & NK-Cell Engaging Bispecific Antibodies.
Chapter 14 and 15, to describe T-Cell & NK-Cell Engaging Bispecific Antibodies sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 T-Cell Engagers
- 1.3.3 NK-Cell Engagers
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hematological Cancers
- 1.4.3 Solid Tumors
- 1.5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size & Forecast
- 1.5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity (2019-2030)
- 1.5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Amgen
- 2.1.1 Amgen Details
- 2.1.2 Amgen Major Business
- 2.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Amgen Recent Developments/Updates
- 2.2 Immunocore
- 2.2.1 Immunocore Details
- 2.2.2 Immunocore Major Business
- 2.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Immunocore Recent Developments/Updates
- 2.3 Johnson & Johnson
- 2.3.1 Johnson & Johnson Details
- 2.3.2 Johnson & Johnson Major Business
- 2.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Johnson & Johnson Recent Developments/Updates
- 2.4 Roche
- 2.4.1 Roche Details
- 2.4.2 Roche Major Business
- 2.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Roche Recent Developments/Updates
- 2.5 Pfizer
- 2.5.1 Pfizer Details
- 2.5.2 Pfizer Major Business
- 2.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Pfizer Recent Developments/Updates
- 2.6 AbbVie
- 2.6.1 AbbVie Details
- 2.6.2 AbbVie Major Business
- 2.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 AbbVie Recent Developments/Updates
- 2.7 MacroGenics
- 2.7.1 MacroGenics Details
- 2.7.2 MacroGenics Major Business
- 2.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.7.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 MacroGenics Recent Developments/Updates
- 2.8 Regeneron
- 2.8.1 Regeneron Details
- 2.8.2 Regeneron Major Business
- 2.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product and Services
- 2.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Regeneron Recent Developments/Updates
3 Competitive Environment: T-Cell & NK-Cell Engaging Bispecific Antibodies by Manufacturer
- 3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Manufacturer (2019-2024)
- 3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of T-Cell & NK-Cell Engaging Bispecific Antibodies by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturer Market Share in 2023
- 3.4.3 Top 6 T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturer Market Share in 2023
- 3.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Market: Overall Company Footprint Analysis
- 3.5.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market: Region Footprint
- 3.5.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market: Company Product Type Footprint
- 3.5.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region
- 4.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Region (2019-2030)
- 4.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Region (2019-2030)
- 4.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Region (2019-2030)
- 4.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value (2019-2030)
- 4.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value (2019-2030)
- 4.4 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value (2019-2030)
- 4.5 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value (2019-2030)
- 4.6 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Type (2019-2030)
- 5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Type (2019-2030)
- 5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Application (2019-2030)
- 6.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Application (2019-2030)
- 6.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Application (2019-2030)
7 North America
- 7.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Type (2019-2030)
- 7.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Application (2019-2030)
- 7.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
- 7.3.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Country (2019-2030)
- 7.3.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Type (2019-2030)
- 8.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Application (2019-2030)
- 8.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
- 8.3.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Country (2019-2030)
- 8.3.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region
- 9.3.1 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Type (2019-2030)
- 10.2 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Application (2019-2030)
- 10.3 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
- 10.3.1 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Country (2019-2030)
- 10.3.2 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
- 11.3.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
- 12.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
- 12.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of T-Cell & NK-Cell Engaging Bispecific Antibodies and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of T-Cell & NK-Cell Engaging Bispecific Antibodies
- 13.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Typical Distributors
- 14.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on T-Cell & NK-Cell Engaging Bispecific Antibodies. Industry analysis & Market Report on T-Cell & NK-Cell Engaging Bispecific Antibodies is a syndicated market report, published as Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
